We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Novartis AG | NYSE:NVS | NYSE | Depository Receipt |
Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-0.07 | -0.07% | 97.27 | 97.91 | 97.07 | 97.75 | 1,045,661 | 21:35:13 |
By Sara Sjolin, MarketWatch
LONDON (MarketWatch) -- European stock markets were on track to break a two-day losing streak on Tuesday, with heavyweights such as UBS AG, Novartis AG and BP PLC heading north after well-received earnings reports.
The broad-based gains came after most markets slumped on Monday, as banks moved sharply lower after stress-test results from the European Central Bank and European Banking Authority. Read: Banks shares catch a cold even after surviving health check
Market reaction: The Stoxx Europe 600 index climbed 0.7% to 327.44 on Tuesday, recovering from a 0.6% slide on Monday.
Germany's DAX 30 index rallied 1.3% to 9,023.64, as all companies in the benchmark traded in positive territory.
France's CAC 40 index added 0.4% to 4,114.78, while the U.K.'s FTSE 100 index rose 0.5% to 6,393.66.
Earnings: Shares of Novartis rose 2.4% after the Swiss drug maker said third-quarter profit jumped 44%.
UBS (UBS) added 3.4% after the Swiss bank reported a rise in third-quarter earnings, although it said it was hit by 1.8 billion Swiss francs ($1.9 billion) in legal provisions.
BP (BP) rose 0.5%, after the energy major said it will raise dividends for the third quarter to 10 cents, a 5.3% increase on the year. The company also said Russia sanctions have had no material impact on the company, although it has felt a squeeze from the falling ruble.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Novartis Chart |
1 Month Novartis Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions